Respiratory protection during high-fidelity simulated resuscitation of casualties contaminated with chemical warfare agents

Anaesthesia

Volumn 63, Issue 6, 2008, Pages 593-598

  Schumacher, J ^a   Runte, J ^b   Brinker, A ^c   Prior, K ^d   Heringlake, M ^b   Eichler, W ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LÜBECK   (Germany)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIR PURIFYING RESPIRATOR; CHEMICAL WARFARE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; EMERGENCY HEALTH SERVICE; EVALUATION; EYE PROTECTIVE DEVICE; FEMALE; GAS MASK; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; RESCUE PERSONNEL; RESUSCITATION; SIMULATION; SKILL; VICTIM; VISOR;

ANESTHESIOLOGY; ATTITUDE OF HEALTH PERSONNEL; CHEMICAL WARFARE AGENTS; CLINICAL COMPETENCE; CROSS-OVER STUDIES; EMERGENCY SERVICE, HOSPITAL; EQUIPMENT DESIGN; GERMANY; HUMANS; MANIKINS; OCCUPATIONAL EXPOSURE; RESPIRATORY PROTECTIVE DEVICES; RESUSCITATION;

EID: 43549116788     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2008.05450.x     Document Type: Conference Paper

References (40)

1. Baker DJ. Management of casualties from terrorist chemical and biological attack: a key role for the anaesthetist. British Journal of Anaesthesia 2002 89:211 4.
2. Baker DJ. Chemical and biological warfare agents: the role of the anesthesiologist. In Miller RA ed. Anesthesia. 6th edition. New York:Churchill Livingstone, 2004:2497 526.
3. de Jong RH. Nerve gas terrorism: a grim challenge to anesthesiologists. Anesthesia and Analgesia 2003 96:819 25.
4. White SM. Chemical and biological weapons; implications for anaesthesia and intensive care. British Journal of Anaesthesia 2002 89:306 24.
5. Kenar L, Karayilanoglu T. Medical preparedness against chemical and biological incidents for the NATO Summit in Istanbul and lessons learned. Prehospital and Disaster Medicine 2006 21:268 71.
6. Lockey D, Davies G. The challenges of deliberate chemical/biological attack. Resuscitation 2003 58:293 6.
7. Han KH, Walker R, Kuhri M. An integrated response to chemical incidents-the UK perspective. Resuscitation 1999 42:133 40.
8. Laurent JF, Richter F, Michel A. Management of victims of urban chemical attack: the French approach. Resuscitation 1999 42:141 9.
9. Sardesai AM, Brown NM, Menon DK. Deliberate release of biological agents. Anaesthesia 2002 57:1067 82.
10. Gould G, Kerr S, Prophet N. Preparation for terrorist attacks. Anaesthesia 2004 59:199.
11. Okumura T, Takasu N, Ishimatsu S, et al. Report on 640 victims of the Tokyo subway sarin attack. Annals of Emergency Medicine 1996 28:129 35.
12. Nozaki H, Hori S, Shinozawa Y, et al. Secondary exposure of medical staff to sarin vapor in the emergency room. Intensive Care Medicine 1995 21:1032 5.
13. Masuda N, Takatsu M, Morinari H, Ozawa T. Sarin poisoning in Tokyo subway. Lancet 1995 345:1446.
14. Weinstein RS, Alibek K. Biological and Chemical Terrorism. A guide for Healthcare Providers and First Responders. New York:Thieme Medical Publishers, 2003, section 3 and 6.
15. Tokuda Y, Kikuchi M, Takahashi O, Stein GH. Prehospital management of sarin nerve gas terrorism in urban settings: 10 years of progress after the Tokyo subway sarin attack. Resuscitation 2006 68:193 202.
16. Hartmann A, Herzog T, Drinkmann A. Psychotherapy of Bulimia Nervosa: what is effective? A meta-analysis Journal of Psychosomatic Research 1992 36:159 67.
17. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomised trials: explanation and elaboration. Annals of Internal Medicine 2001 134:663 94.
18. Lee EC. Clinical manifestations of sarin nerve gas exposure. Journal of the American Medical Association 2003 290:659 62.
19. Evison D, Hinsley D, Rice P. Chemical weapons. British Medical Journal 2002 324:332 5.
20. Gosden C, Gardener D. Weapons of mass destruction - threats and responses. British Medical Journal 2005 331:397 400.
21. Ben Abraham R, Rudick V, Weinbroum AA. Practical guidelines for acute care of victims of bioterrorism: conventional injuries and concomitant nerve agent intoxication. Anesthesiology 2002 97:989 1004.
22. Nakajima T, Sato S, Morita H, Yanagisawa N. Sarin poisoning of a rescue team in the Matsumoto sarin incident in Japan. Journal of Occupational and Environmental Medicine 1997 54:697 701.
23. US Army Medical Research Institute. Medical Management of Chemical Casualties Handbook, 3th edn. US Army Medical Research Institute of Chemical Defense (USAMRICD) McLean:International Medical Publishing, Inc, 2002, pp. 175 207.
24. Bradley RN. Health care facility preparation for weapons of mass destruction. Prehospital Emergency Care 2000 4:261 9.
25. Flaishon R, Sotman A, Friedman A, Ben-Abraham R, Rudick V, Weinbroum AA. Laryngeal mask airway insertion by anesthetists and non-anaesthetists wearing unconventional protective gear: a prospective, randomized, crossover study in humans. Anesthesiology 2004 100:267 73.
26. Flaishon R, Sotman A, Ben-Abraham R, Rudick V, Varssano D, Weinbroum AA. Antichemical protective gear prolongs time to successful airway management: a randomized, crossover study in humans. Anesthesiology 2004 100:260 6.
27. Vardi A, Berkenstadt H, Levin I, Bentencur A, Ziv A. Intraosseous vascular access in the treatment of chemical warfare casualties assessed by advanced simulation: proposed alteration of treatment protocol. Anesthesia and Analgesia 2004 98:1753 8.
28. World Health Organization. Public health response to biological and chemical weapons. WHO guidance. - Annex 4. Principles of protection. Geneva:WHO, 2004. http://www.who.int/csr/delibepidemics/biochemguide/en/ (last accessed: 1 February 2008).
29. Martyny J, Glazer CS, Newman LS. Respiratory protection. New England Journal of Medicine 2002 347:824 30.
30. Berkenstadt H, Ziv A, Barsuk D, Levine I, Cohen A, Vardi A. The use of advanced simulation in the training of anesthesiologists to treat chemical warfare casualties. Anesthesia and Analgesia 2003 96:1739 42.
31. Subbarao I, Bond WF, Johnson C, Hsu EB, Wasser TE. Using innovative simulation modalities for civilian-based, chemical, biological, radiological, nuclear, and explosive training in the acute management of terrorist victims: a pilot study. Prehospital and Disaster Medicine 2006 21:272 5.
32. Arad M, Berkenstadt H, Zelingher J, Laor A, Shemer J, Atsmon J. The effects of continuous operation in a chemical protective ensemble on the performance of medical tasks in trauma management. The Journal of Trauma 1993 35:800 4.
33. Fine BJ, Kobrick JL. Effect of heat and chemical protective clothing on cognitive performance. Aviation, Space, and Environmental Medicine 1987 58:149 54.
34. Zelnick SD, McKay RT, Lockey JE. Visual field loss while wearing full-face respiratory protection. American Industrial Hygiene Association Journal 1994 55:315 21.
35. McAlister WH, Wingert TA, Bachman WG, Buckingham RS. Visual field restrictions with the M17 series protective mask. Journal of the American Optometric Association 1991 62:849 52.
36. McAlister WH, Buckingham RS, Wingert TA. A comparison of the visual field restrictions with the M17 series protective mask and the MCU-2/P chemical-biological mask. Military Medicine 1993 158:266 9.
37. Samo DG, Bahk JK, Gerkin RD. Effect of firefighter masks on monocular and binocular peripheral vision. Journal of Occupational and Environmental Medicine 2003 45:428 32.
38. King Jm, Frelin AJ. Impact of the chemical protective ensemble on the performance of basic medical tasks. Military Medicine 1984 149:496 501.
39. Baker DJ. Management of respiratory failure in toxic disasters. Resuscitation 1999 42:125 31.
40. Karalliedde L. Organophosphorus poisoning and anaesthesia. Anaesthesia 1999 54:1073 88.